0
0
Date: December 5, 2025
BERLIN — In a world obsessed with biohacking and the promise of radical life extension, a provocative new analysis is sounding a note of caution: living to 100 doesn’t necessarily mean you have slowed down your biological clock.
A landmark review published this week in the journal Genomic Psychiatry argues that modern medicine has successfully extended human lifespan by treating specific diseases, but it has largely failed to slow the fundamental process of aging itself. The distinction, researchers warn, is critical. Conflating “not dying” with “not aging” may be leading scientists and consumers down a blind alley of false hope and misdirected treatments.
“When we say an intervention ‘slows aging,’ what do we actually mean?” asks Dr. Dan Ehninger, lead author of the study and head of the Translational Biogerontology Laboratory at the German Center for Neurodegenerative Diseases (DZNE). “Our analysis suggests that many widely used proxies for aging—including lifespan extension and epigenetic clocks—often blur two distinct ideas: altering the pace at which aging unfolds, versus simply shifting the body’s state in ways that don’t depend on age at all.”
The “Uncoupling” Hypothesis
The core of Ehninger and co-author Dr. Maryam Keshavarz’s argument is what they call the “uncoupling” of lifespan and aging rate.
For decades, the “gold standard” for testing anti-aging drugs in the lab has been simple: does the mouse (or worm, or fly) live longer? If the answer is yes, the drug is often hailed as an anti-aging breakthrough.
But the new report challenges this logic by analyzing the primary causes of death across species. In humans, cardiovascular disease accounts for 35% to 70% of deaths in older adults. In laboratory mice, nearly 90% of age-related deaths are caused by specific cancers (neoplasia).
“This pattern illustrates that interventions targeting specific pathologies can extend lifespan by addressing critical bottlenecks to survival, but they do not necessarily slow the overall aging process,” the authors write.
In other words, curing a mouse’s cancer might let it live weeks longer, just as bypass surgery might buy a human another decade. But in both cases, the underlying biological deterioration—the greying hair, the stiffening joints, the cognitive decline—marches on at the same relentless pace. We are surviving the specific diseases that used to kill us, only to live long enough to experience the full brunt of aging.
Cracks in the “Hallmarks of Aging”
Perhaps most controversial is the study’s critique of the “Hallmarks of Aging,” the influential framework that defines aging by cellular traits like genomic instability and mitochondrial dysfunction.
Ehninger and Keshavarz conducted a systematic review of the primary studies cited to support these hallmarks. They found a striking methodological gap: between 56% and 99% of the supporting evidence relied on experiments where treatments were tested only in aged animals, without young control groups.
Without testing young animals, it is impossible to tell if a treatment is actually slowing the rate of aging (which should affect the trajectory of change over time) or simply providing a temporary boost to health that would happen at any age.
“Consequently, the evidence cited for most hallmarks supports the presence of general physiological effects rather than true anti-aging mechanisms,” the researchers concluded.
Expert Perspectives
The findings have sparked immediate discussion in the geroscience community, echoing concerns that have been simmering as the “longevity economy” booms.
Dr. S. Jay Olshansky, a professor of epidemiology at the University of Illinois Chicago who was not involved in the new study, suggests the findings align with demographic reality.
“Most people alive today at older ages are living on ‘manufactured time’ created by medicine,” Olshansky notes. “These medical ‘band-aids’ are producing fewer years of life even though they’re occurring at an accelerated pace. Unless the processes of biological aging can be markedly slowed, radical human life extension is implausible.”
Similarly, Dr. Will Mair of the Harvard T.H. Chan School of Public Health has previously warned against confusing life expectancy with biological resilience. “Those additional years have absolutely nothing to do with making our bodies intrinsically age slower,” Mair stated in a recent interview. “We’ve added a phenomenal amount of time… but the problems of aging have just shifted to later in life.”
The Trouble with Clocks
The Genomic Psychiatry paper also takes aim at “epigenetic clocks”—chemical tests that analyze DNA to estimate a person’s “biological age.” These tests have become popular consumer products, sold with promises that specific diets or supplements can “reverse” your age.
The researchers caution that these clocks are largely correlational. They are trained to predict chronological age or mortality risk, but that doesn’t mean they measure the biological mechanism of aging. A “younger” clock score might simply reflect a boosted immune system or lower inflammation levels—beneficial changes, certainly, but not proof that the aging process itself has been decelerated.
Implications for Public Health
For the average health-conscious consumer, this research serves as a reality check.
-
Skepticism is Healthy: Be wary of supplements or protocols claiming to “reverse aging” based solely on epigenetic clock data or animal lifespan studies.
-
Healthspan over Lifespan: The goal of health interventions should shift from simply “living longer” to “living healthier.” An intervention that prevents heart disease is valuable even if it doesn’t slow aging—but it should be marketed as a heart health tool, not an anti-aging elixir.
-
Focus on Function: Rather than obsessing over molecular biomarkers, focus on functional metrics: mobility, cognitive sharpness, and metabolic health. These remain the most reliable indicators of quality of life.
“The longevity riddle remains,” the study concludes. “Why do the evolutionary forces that shaped human aging provide a license to alter the level of health but not the rate of debilitation?” Until science can answer that, living well remains a different challenge than just living long.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
Primary Study:
-
Ehninger, D., & Keshavarz, M. (2025). “Beyond the hallmarks of aging: Rethinking what aging is and how we measure it.” Genomic Psychiatry. DOI: 10.61373/gp025w.0119. Published Dec 2, 2025.
